Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SMAD1 is a key intracellular signal transducer and transcriptional modulator in the TGF-β superfamily, particularly for BMP signaling. Upon activation by BMP type I receptor kinases, SMAD1 forms complexes with co-SMADs like SMAD4 and translocates to the nucleus to regulate gene expression involved in cell growth, apoptosis, morphogenesis, development, immune responses, and tissue homeostasis. Dysregulation is linked to developmental and cardiovascular diseases.
Not applicable as a direct drug target itself but modulated through upstream BMP receptor signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Smad family member 1 (SMAD1).